These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Prevention of cytomegalovirus in organ transplantation]. Aguado JM Rev Clin Esp; 1996 Apr; 196(4):240-7. PubMed ID: 8701064 [No Abstract] [Full Text] [Related]
6. Antiviral strategies to combat cytomegalovirus infections in transplant recipients. Lischka P; Zimmermann H Curr Opin Pharmacol; 2008 Oct; 8(5):541-8. PubMed ID: 18662804 [TBL] [Abstract][Full Text] [Related]
7. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Schleiss MR Rev Med Virol; 2006; 16(2):73-82. PubMed ID: 16287195 [TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Fisher RA Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345 [TBL] [Abstract][Full Text] [Related]
9. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation]. Schuler U; Ehninger G Med Klin (Munich); 1992 Oct; 87 Suppl 1():30-8. PubMed ID: 1334220 [No Abstract] [Full Text] [Related]
10. Combination antiviral strategies in managing cytomegalovirus infection. Martin M Transplant Proc; 1994 Oct; 26(5 Suppl 1):28-30. PubMed ID: 7940973 [No Abstract] [Full Text] [Related]
15. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor. Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311 [TBL] [Abstract][Full Text] [Related]
16. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know. Meylan PR; Pascual M Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369 [No Abstract] [Full Text] [Related]
17. Monitoring transplant patients for human cytomegalovirus: Diagnostic update. Gerna G; Lilleri D Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Steininger C Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749 [TBL] [Abstract][Full Text] [Related]
19. Defining an optimal regimen for cytomegalovirus prophylaxis in organ transplant recipients. Paya CV Transplant Proc; 1996 Dec; 28(6 Suppl 2):9-11. PubMed ID: 9037269 [No Abstract] [Full Text] [Related]
20. [Prophylaxis of cytomegalovirus infection in the transplant recipient]. Aguado JM; Lumbreras C; Otero JR Med Clin (Barc); 1992 Oct; 99(11):430-4. PubMed ID: 1335103 [No Abstract] [Full Text] [Related] [Next] [New Search]